Dow Down 1.40% Nasdaq Down 1.59%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.12 Up 0.01(0.90%) 4:00PM EDT
Prev Close:1.11
Open:1.11
Bid:1.11 x 4400
Ask:1.12 x 6900
1y Target Est:1.67
Beta:0.71
Next Earnings Date:N/A
Day's Range:1.10 - 1.16
52wk Range:1.00 - 2.35
Volume:614,409
Avg Vol (3m):533,842
Market Cap:57.98M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVEO

Comparison

Symbol% ChgMkt Cap
AVEOUp 0.90%57.98M
AMGNDown 1.17%105.45B
PFEDown 1.42%184.84B
RHHBYDown 0.68%249.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback